British Gynaecological Cancer Society/British Association of Gynaecological Pathology consensus for germline and tumor testing for BRCA1/2 variants in ovarian cancer in the United Kingdom

Research output: Contribution to journalReview articlepeer-review

Standard

British Gynaecological Cancer Society/British Association of Gynaecological Pathology consensus for germline and tumor testing for BRCA1/2 variants in ovarian cancer in the United Kingdom. / Sundar, Sudha; Manchanda, Ranjit; Gourley, Charlie; George, Angela; Wallace, Andrew; Balega, Janos; Williams, Sarah; Wallis, Yvonne; Edmondson, Richard; Nicum, Shibani; Frost, Jonathan; Attygalle, Ayoma; Fotopoulou, Christina; Bowen, Rebecca; Bell, Dani; Gajjar, Ketankumar; Ramsay, Bruce; Wood, Nicholas J; Ghaem-Maghami, Sadaf; Miles, Tracie; Ganesan, Raji.

In: International Journal of Gynecological Cancer, Vol. 31, No. 2, 01.02.2021, p. 272-278.

Research output: Contribution to journalReview articlepeer-review

Harvard

Sundar, S, Manchanda, R, Gourley, C, George, A, Wallace, A, Balega, J, Williams, S, Wallis, Y, Edmondson, R, Nicum, S, Frost, J, Attygalle, A, Fotopoulou, C, Bowen, R, Bell, D, Gajjar, K, Ramsay, B, Wood, NJ, Ghaem-Maghami, S, Miles, T & Ganesan, R 2021, 'British Gynaecological Cancer Society/British Association of Gynaecological Pathology consensus for germline and tumor testing for BRCA1/2 variants in ovarian cancer in the United Kingdom', International Journal of Gynecological Cancer, vol. 31, no. 2, pp. 272-278. https://doi.org/10.1136/ijgc-2020-002112

APA

Sundar, S., Manchanda, R., Gourley, C., George, A., Wallace, A., Balega, J., Williams, S., Wallis, Y., Edmondson, R., Nicum, S., Frost, J., Attygalle, A., Fotopoulou, C., Bowen, R., Bell, D., Gajjar, K., Ramsay, B., Wood, N. J., Ghaem-Maghami, S., ... Ganesan, R. (2021). British Gynaecological Cancer Society/British Association of Gynaecological Pathology consensus for germline and tumor testing for BRCA1/2 variants in ovarian cancer in the United Kingdom. International Journal of Gynecological Cancer, 31(2), 272-278. https://doi.org/10.1136/ijgc-2020-002112

Vancouver

Author

Sundar, Sudha ; Manchanda, Ranjit ; Gourley, Charlie ; George, Angela ; Wallace, Andrew ; Balega, Janos ; Williams, Sarah ; Wallis, Yvonne ; Edmondson, Richard ; Nicum, Shibani ; Frost, Jonathan ; Attygalle, Ayoma ; Fotopoulou, Christina ; Bowen, Rebecca ; Bell, Dani ; Gajjar, Ketankumar ; Ramsay, Bruce ; Wood, Nicholas J ; Ghaem-Maghami, Sadaf ; Miles, Tracie ; Ganesan, Raji. / British Gynaecological Cancer Society/British Association of Gynaecological Pathology consensus for germline and tumor testing for BRCA1/2 variants in ovarian cancer in the United Kingdom. In: International Journal of Gynecological Cancer. 2021 ; Vol. 31, No. 2. pp. 272-278.

Bibtex

@article{311cb1f91e0846c896006a0fc6706f0a,
title = "British Gynaecological Cancer Society/British Association of Gynaecological Pathology consensus for germline and tumor testing for BRCA1/2 variants in ovarian cancer in the United Kingdom",
abstract = "The British Gynecological Cancer Society and the British Association of Gynecological Pathologists established a multidisciplinary consensus group comprising experts in surgical gynecological oncology, medical oncology, genetics, and laboratory science, and clinical nurse specialists to identify the optimal pathways to BRCA germline and tumor testing in patients with ovarian cancer in routine clinical practice. In particular, the group explored models of consent, quality standards identified at pathology laboratories, and experience and data from pioneering cancer centers. The group liaised with representatives from ovarian cancer charities to also identify patient perspectives that would be important to implementation. Recommendations from these consensus group deliberations are presented in this manuscript.",
keywords = "BRCA1 protein, BRCA2 protein, fallopian tube neoplasms, ovarian neoplasms",
author = "Sudha Sundar and Ranjit Manchanda and Charlie Gourley and Angela George and Andrew Wallace and Janos Balega and Sarah Williams and Yvonne Wallis and Richard Edmondson and Shibani Nicum and Jonathan Frost and Ayoma Attygalle and Christina Fotopoulou and Rebecca Bowen and Dani Bell and Ketankumar Gajjar and Bruce Ramsay and Wood, {Nicholas J} and Sadaf Ghaem-Maghami and Tracie Miles and Raji Ganesan",
note = "{\textcopyright} IGCS and ESGO 2021. No commercial re-use. See rights and permissions. Published by BMJ.",
year = "2021",
month = feb,
day = "1",
doi = "10.1136/ijgc-2020-002112",
language = "English",
volume = "31",
pages = "272--278",
journal = "International Journal of Gynecological Cancer",
issn = "1525-1438",
publisher = "Lippincott Williams and Wilkins",
number = "2",

}

RIS

TY - JOUR

T1 - British Gynaecological Cancer Society/British Association of Gynaecological Pathology consensus for germline and tumor testing for BRCA1/2 variants in ovarian cancer in the United Kingdom

AU - Sundar, Sudha

AU - Manchanda, Ranjit

AU - Gourley, Charlie

AU - George, Angela

AU - Wallace, Andrew

AU - Balega, Janos

AU - Williams, Sarah

AU - Wallis, Yvonne

AU - Edmondson, Richard

AU - Nicum, Shibani

AU - Frost, Jonathan

AU - Attygalle, Ayoma

AU - Fotopoulou, Christina

AU - Bowen, Rebecca

AU - Bell, Dani

AU - Gajjar, Ketankumar

AU - Ramsay, Bruce

AU - Wood, Nicholas J

AU - Ghaem-Maghami, Sadaf

AU - Miles, Tracie

AU - Ganesan, Raji

N1 - © IGCS and ESGO 2021. No commercial re-use. See rights and permissions. Published by BMJ.

PY - 2021/2/1

Y1 - 2021/2/1

N2 - The British Gynecological Cancer Society and the British Association of Gynecological Pathologists established a multidisciplinary consensus group comprising experts in surgical gynecological oncology, medical oncology, genetics, and laboratory science, and clinical nurse specialists to identify the optimal pathways to BRCA germline and tumor testing in patients with ovarian cancer in routine clinical practice. In particular, the group explored models of consent, quality standards identified at pathology laboratories, and experience and data from pioneering cancer centers. The group liaised with representatives from ovarian cancer charities to also identify patient perspectives that would be important to implementation. Recommendations from these consensus group deliberations are presented in this manuscript.

AB - The British Gynecological Cancer Society and the British Association of Gynecological Pathologists established a multidisciplinary consensus group comprising experts in surgical gynecological oncology, medical oncology, genetics, and laboratory science, and clinical nurse specialists to identify the optimal pathways to BRCA germline and tumor testing in patients with ovarian cancer in routine clinical practice. In particular, the group explored models of consent, quality standards identified at pathology laboratories, and experience and data from pioneering cancer centers. The group liaised with representatives from ovarian cancer charities to also identify patient perspectives that would be important to implementation. Recommendations from these consensus group deliberations are presented in this manuscript.

KW - BRCA1 protein

KW - BRCA2 protein

KW - fallopian tube neoplasms

KW - ovarian neoplasms

UR - http://www.scopus.com/inward/record.url?scp=85099803630&partnerID=8YFLogxK

U2 - 10.1136/ijgc-2020-002112

DO - 10.1136/ijgc-2020-002112

M3 - Review article

C2 - 33468564

VL - 31

SP - 272

EP - 278

JO - International Journal of Gynecological Cancer

JF - International Journal of Gynecological Cancer

SN - 1525-1438

IS - 2

ER -